Sangui BioTech International IncOver The Counter Market:SGBI
- LAST PRICE0.0015
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0015
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sangui BioTech International Inc | 314.9K | -2.5x | --- |
Yield10 Bioscience Inc | 363.7K | 0.0x | --- |
Navidea Biopharmaceuticals Inc | 100.1K | 0.0x | --- |
Endonovo Therapeutics Inc | 317.5K | 0.0x | --- |
Neximmune Inc | 338.7K | 0.0x | --- |
Multicell Technologies Inc | 5.0K | 0.0x | --- |
Company Information
Sangui Biotech International, Inc. focuses on the development of pharmaceutical, medical and cosmetic products. The Company develops its products through its German subsidiary, SanguiBioTech AG (Sangui GmbH). It is engaged in seeking to market and selling its products through partnerships with industry partners across the world. It focuses on the development of oxygen carriers capable of providing oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia or blood loss whether due to surgery, trauma, or other causes. It focuses its development and commercialization efforts on such artificial oxygen carriers by reproducing and synthesizing polymers out of native hemoglobin of defined molecular sizes. It offers external applications of oxygen transporters in the medical and cosmetic fields in the form of sprays for the healing of chronic wounds and of gels and emulsions for the regeneration of the skin.
Contact Information
- Headquarters
- c/o SanguiBioTech GmbH c/o HRH GmbH, Bleichenbruecke 9HAMBURG, Germany 20354
- Phone
- 404-609-3120
- Fax
- ---
Executives
- Chief Executive Officer, Chief Financial Officer, Director
- Thomas Striepe
- Non-Executive Director
- Hubertus Schmelz
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $314.9K |
|---|---|
Revenue (TTM) | $80.9K |
Shares Outstanding | 209.9M |
Sangui BioTech International Inc does not pay a dividend. | |
Beta | 1.05 |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -2.5x |
Price/Sales (TTM) | 3.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -141.36% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
